Oral L-citrulline and Transresveratrol Supplementation Improves Erectile Function in Men With Phosphodiesterase 5 Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Crossover Pilot Study

Introduction: Phosphodiesterase type 5 inhibitors (PDE5i) are first-line therapy for most men with erectile dysfunction (ED). If ineffective, vacuum erection devices, intracavernous injections, and penile prosthesis implantation are suitable as second- or third-line therapies. However, very few pati...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Masato Shirai, MD, PhD, Ippei Hiramatsu, MD, Yusuke Aoki, MD, Hirofumi Shimoyama, MD, PhD, Taiki Mizuno, MD, PhD, Taiji Nozaki, MD, PhD, Shinichiro Fukuhara, MD, PhD, Atsushi Iwasa, MD, PhD, Shinji Kageyama, MD, PhD, Akira Tsujimura, MD, PhD
Format:	Artigo
Język:	Inglês
Wydane:	Oxford University Press 2018-12-01
Seria:	Sexual Medicine
Dostęp online:	http://www.sciencedirect.com/science/article/pii/S2050116118300618
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!